Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model

British Journal of Cancer

Volumn 68, Issue 1, 1993, Pages 69-73

  Pedley, R B ^a   Boden, J A ^a   Boden, R ^a   Dale, R ^b   Begent, R H J ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CARCINOEMBRYONIC ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IODINE 131;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; BETA RADIATION; CANCER INHIBITION; COLON TUMOR; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMAL; ANTIBODIES; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOGLOBULINS, FAB; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0027245812     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1993.288     Document Type: Article

References (20)

1. BEGENT, R.H.J., LEDERMANN, J.A., GREEN, A.J., BAGSHAWE, K.D., RIGGS, S.J., SEARLE, F., KEEP, P.A., ADAM, T., DALE, R.G. & GLASER, M.G. (1989). Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. Br. J. Cancer, 60, 406-412.
2. BEGENT, R.HJ. & PEDLEY, R.B. (1990). Antibody targeted therapy in cancer: comparison of murine and clinical studies. Cancer Treatment Rev., 17, 373-378.
3. 2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med., 31, 1035-1044.
4. 2 fragments. J. Clin. Invest., 83, 1449-1456.
5. BUCHEGGER, R., VACCA, A., CARREL, S., SCHREYER, M. & MACH, J.-P. (1988). Radioimmunotherapy of human colon carcinoma by 1311 labeled monoclonal anti-CEA antibodies in the nude mouse model. Int. J. Cancer, 41, 127-134.
6. 2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J. Natl Cancer Inst., 77, 739-745.
7. DALE, R.G. (1989). Radiobiological assessment of permanent implants using tumour repopulation factors in the linear quadratic model. Br. J. Radiol., 62, 241-244.
8. DENARDO, S.J., DENARDO, G.L., O’GRADY, L.F., LEVY, M B., MILLS, S.L., MACEY, D.J., MCGAHAN, J.P., MILLER, C.H. & EPSTEIN, A.L. (1988). Pilot studies of radioimmunotherapy of B cell lymphoma and leukemia using 1-131 Lym-1 monoclonal antibodies. Antibody Immunoconj. Radiophar., 1, 17-33.
9. FOWLER, J.F. (1990). Radiobiological aspects of low dose rates in radioimmunotherapy. Int. J. Rad. Oncol. Biol. Phys., 18, 1261-1269.
10. HARWOOD, P.J., BODEN, J., PEDLEY, R.B., RAWLINS, G., ROGERS, G.T. & BAGSHAWE, K.D., (1985). Comparative tumour localization of antibody fragments and intact IgG in nude mice bearing a CEA-producing human colon tumour xenograft. Eur. J. Cancer Clin. Oncol., 21, 1515-1522.
11. HUMM, J.L. & COBB, L.M. (1990). Nonuniformity of tumour dose in radioimmunotherapy. J. Nucl. Med., 31, 75-83.
12. JEFFREY, A. (1985). Mathematics for Engineers and Scientists, third edition. Van Nostrand Reinhold (UK) Co. Ltd.
13. LEE, E. & DESU, M. (1972). A computer program for comparing K samples with right-censored data. Computer Prog. Biomed., 2, 315-321.
14. LOONEY, W.B., MAYO, A.A., ALLEN, P.M., MORROW, J.Y. & MORRIS, H.P. (1973). A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatoma. Br. J. Cancer, 27, 341-344.
15. 3I-labelled anti-CEA antibodies in a humancolonic xenograft model. Int. J. Cancer, 47, 597-602.
16. PEDLEY, R.B., BODEN, J., KEEP, P.A., HARWOOD, P.J., GREEN, A.J. & ROGERS, G.T. (1987). Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Europ. J. Nucl. Med., 13, 197-202.
17. PEDLEY, R.B., DALE, R., BODEN, J.A., BEGENT, R.H.J., KEEP, P.A. & GREEN, A.J. (1989). The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model. Int. J. Cancer, 43, 713-718.
18. SCHLOM, J., MOLINOLO, A., SIMPSON, J.F., SILER, K., ROSELLI, M., HINKLE, G., HOUCHENS, D.P. & COLCHER, D. (1990). Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J.N.C.I., 82, 763-771.
19. SHARKEY, R.M., PYKETT, M.J., SIEGEL, J.A., ALGER, E.A., PRIMUS, F.J. & GOLDENBERG, D.M. (1987). Radioimmunotherapy of the GW-39 human colonic tumour xenograft with 1311-labeled murine monoclonal antibody to carcinoembronic antigen. Cancer Res., 47, 5672-5677.
20. TOM, B.H., RUTZKY, L.H., JAKSTYS, M.M., OYASU, R., KAYE, C.I. & KAHAN, B.D. (1976). Human colonic adenocarcinoma cells. 1. Establishment and description of a new cell line. In Vitro, 12, 180-181.